Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis Authors: Tope Oyelade, Arowosegbe Abayomi, Sulaiman M Almarkhan, Fahad A Salem, Jaber S Alqahtani Published: 2026 ABSTRACT AbstractBackground:MSK (musculoskeletal) disorders (MSDs) significantly limit physical activity and the general quality of life of patients. Prison inmates have poor access to quality health care, which may hinder their rehabilitation journey. This study assessed the prevalence of MSDs among prison inmates.Methods:Electronic databases were searched from inception to July 2025. Studies were screened, and relevant data were extracted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. A meta-analysis was conducted using a random-effects model to pool the prevalence of MSDs among inmates. The quality of studies was assessed using the Newcastle-Ottawa Scale, and bias was measured using the funnel plot, the Egger test, and leave-one-out sensitivity analysis.Results:A total of 16 studies were included from 1089 initially retrieved from database searches. A total of 21 536 prison inmates were included in these studies, of which 4016 had MSDs. Pooled prevalence of overall MSDs (diagnosed and self-reported) among prisoners was 25% (95% confidence interval [CI] = 18%-33%). Clinically diagnosed and self-reported MSDs had a prevalence of 18% (95% CI = 13%-24%) and 30% (95% CI = 20%-39%), respectively. The funnel plots and the Egger tests show no publication bias, with sensitivity analyses showing that no single research significantly influences the pooled effect sizes.Conclusions:Musculoskeletal disorders may affect 1 in 4 prison inmates, with associated debilitating effects on both physical and mental health. Given that this population has limited access to quality care and considering that the aim of incarceration is rehabilitation, it is essential to prioritize and address the health effects of MSK disorders among prison inmates.Keywords: prison, inmates, musculoskeletal, osteoarthritis, MSK disorders, meta-analysis Introduction The global population faces an increasing number of musculoskeletal disorders (MSDs), which now affect more than 1.7 billion people and result in chronic pain and disability. 1 The age-standardized global prevalence of MSDs surpassed 1.68 billion cases in 2021, representing a nearly 95% increase since 1990, which disproportionately affects women and older adults. 2 Musculoskeletal disorders encompass conditions like osteoarthritis, back and neck pain, and traumatic orthopaedic injuries. They are a leading cause of years lived with disability across all regions, as highlighted by the World Health Organization. 1 Within inmate populations, MSDs are one of the 10 most common health complaints. These disorders are associated with unique risk factors linked to the prison environment. 3 Studies have shown a high incidence of musculoskeletal (MSK) trauma in prisons, particularly injuries to the hand, wrist, foot, and ankle. 3 The burden of MSDs in the prison environment can be exacerbated by overcrowding, limited access to care, chronic pain, inadequate activity, and poor ergonomic controls.4,5 The complex referral processes, along with under-reporting of symptoms and restrictive security protocols, hinder medical care for many prisoners, leading to delayed diagnoses and long-term rehabilitation.3-5 The management of MSDs in correctional facilities becomes difficult because inmates lack access to specialist consultations and physical therapy services. 3 Additionally, safety protocols limit the use of assistive devices, and security activities often result in missed medical appointments. 3 Studies across different regions show that inmate MSD rates span between 7% and 20%, in which older, disabled, and long-term incarcerated populations tend to have higher rates of these complaints. 5 Although MSDs significantly affect prison health, the existing studies are relatively limited, primarily directed at infectious or mental health conditions instead.5-7 Given the significant potential impact of MSDs among inmates and the distinctive challenges these conditions pose within correctional settings, a systematic review and meta-analysis are essential to consolidate the current body of evidence and deliver accurate burden assessments. Thus, assessing the prevalence of MSDs among prisoners may provide a basis for better understanding of the magnitude of the problem while allowing authorities and decision-makers to better focus on this issue. This systematic review is aimed at evaluating the prevalence of MSDs among prisoners. Methods The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in conducting this meta-analysis, which was registered prospectively in the PROSPERO database (CRD420251120264). 8 Ethical approval or consent was not needed for this study, as it is a systematic review of previously published and openly available data, and no new participants were recruited. Selection Criteria Peer-reviewed studies reporting the prevalence of MSK pain among adult prison inmates were included in this study. People in jail (held without sentence), those detained by police or any other authorities, people held in immigration detention centres, and children held in juvenile prisons were all excluded. Furthermore, conference abstracts, case studies, preprints, letters, and editorials were excluded. We included studies that reported both clinically diagnosed and self-reported MSK pain. Further, to be included, studies must explicitly report the prevalence of MSK disorders among the study population or highlight the prevalence of prison inmates with arthritis as a separate, independent health issue. The aim of this is to reduce variability in reported or diagnosed MSK disorder among included studies. Studies in which the data/prevalence of MSK disorders were combined with other disorders were excluded because the proportion of the combined prevalence of MSK disorders could not be established. Search Strategies For this study, the Allied and Complementary Medicine Database (AMED), MEDLINE, PsycInfo, SPORT Discus, Age Line, CINAHL Plus, PsycArticles, and Academic Search Complete were searched via EBSCOhost as well as Embase to retrieve related studies based on a comprehensive search strategy with relevant medical subject headings (MeSH) terms combined using Boolean operators. The search was conducted to search studies published from inception until July 2025 (see Supplemental Figure S1 for search strategy). Screening and Data Extraction The retrieved studies were uploaded to EndNote to detect and remove duplicate studies. Duplicate-free studies were uploaded to rayyan.ai for independent screening. Title, abstract, and full-text screening were conducted by 2 authors (TO and JSA), with any conflicts regarding inclusion resolved through online deliberation meetings between TO and JSA. Studies deemed relevant to the topic were then compiled, followed by the extraction of data into an Excel file. The extracted data included both qualitative and quantitative information about individual studies, as well as characteristics of the study populations. Data Analysis The prevalence of MSDs and/or arthritis was extracted and analysed. The “meta” package in R (RStudio, 2023.03.0 Build 386, 2009-2023 Posit Software, PBC) was used to pool the prevalence of MSK disorders in included studies using a random-effects model, where between-heterogeneity is significantly high. Separate meta-analyses were performed for self-reported, clinically diagnosed, and total (both self-reported and clinically diagnosed) MSK disorders to assess whether the mode of reporting influences the prevalence. Outputs were generated as forest plots using the “metaprop” and “forest” functions. Quality Assessment To assess the overall quality of included studies, a modified form of the Newcastle-Ottawa Scale (NOS) was used. The NOS covers 3 criteria, which include the quality of the process of participant selection, the comparability (representativeness) of the prison population (ie, random or specific demography), and the reliability of how the MSK disorder was established. The 3 criteria include 6 domains, each scored 1 (if satisfied) or 0 (if not satisfied), with a maximum possible total score of 6. The mean of all scores is calculated (ie, score divided by 6) to obtain an average score between 0 and 1, with lower scores representing lower quality and vice versa. Quality assessment was conducted by one of the authors (AA) and reviewed by 2 other authors (SMA and FAS). Assessment of Bias Publication bias is a significant limitation of most systematic reviews, as positive studies are typically prioritized for publication, while studies with negative or null outcomes are often deemed unpublishable. To assess the effect of publication bias on the pooled prevalence of MSK among prison inmates, a funnel plot was computed for the included study. The “funnel” function” in R allows the visualization of the standard error (x-axis) in comparison with effect size (y-axis) to assess whether there is bias to publish studies with higher MSDs. The funnel plot asymmetry was assessed via the Egger test. Leave-one-out sensitivity analysis was performed to determine the changes in the pooled prevalence resulting from the consecutive removal of each of the included studies. This method utilizes the “metabias” function to assess whether any of the studies exert too much influence on the overall prevalence. For all analysis, a P-value of <.05 defines the level of significance. Results The initial search of all databases yielded a total of 590 non-duplicate studies. Title and abstract screening resulted in the exclusion of 512 studies. The 78 remaining studies were sorted and downloaded for full-text screening, which resulted in the further exclusion of 62 studies that did not meet the inclusion criteria (Figure 1). PRISMA flow chart for prevalence of MSK disorders among prison inmates Characteristics of Included Studies A total of 16 studies were included in this study, with a total of 21 536 prison inmates, of which 4016 (18.65%) were either diagnosed with or self-reported MSDs. Sample sizes of included studies ranged from 497 to 14 373 inmates. Three studies each were conducted in the United Kingdom and the United States, followed by 2 studies each in Switzerland and Australia, with 1 study each from other countries (Table 1). The risk of bias assessment showed that more than half of the included studies (9/16; 56.25%) have a score of ⩾ 0.5, showing that the risk of bias is low (Supplement Table 2). Table 1.Characteristics of Included Studies.AuthorYearCountryStudy designSample sizeFemale (%)Age, mean ± SD/median (IQR)/rangeDuration in prisonMSD self-reportedMSD diagnosedMSD totalArmiya’u et al 9 2013NigeriaCross-sectional descriptive6080.032.1 ± 10.642.9 ± 65.6 months12.12Nolan and Stewart 10 2017CanadaCross-sectional descriptive271100.031.5 ± 11entry to <2 weeks87.87Deonandan et al 11 2012GuyanaRetrospective descriptive108.33.7NR543354Elger et al 12 2004SwitzerlandComparative11312.434 ± 11.5NR.1212Moschetti et al 13 2017SwitzerlandCross-sectional descriptive16648.477% (30-49 y)Entry.213213Washington et al 14 2024The United StatesCross-sectional descriptive8800.060.63 ± 7.366NR386.386Fazel et al 15 2001The United KingdomCross-sectional descriptive2030.065.5 ± 4.816 months884888Murray et al 16 2004AustraliaCross-sectional descriptive49716.920-60NR.7373Lane et al 17 2020The United StatesCross-sectional survey9154.949.4% (⩾60)44.44Priwe and Carlsson 18 2018SwedenCross-sectional survey1860.020-79⩾6 months28.28Binswanger et al 19 2009The United StatesCross-sectional survey1437323.235.6 ± 24NR2480.2480Nobile et al 20 2011ItalyCross-sectional survey6500.039.8 ± 10.5NR210.210Feron et al 21 2005BelgiumRetrospective cohort513.33 (26-40)NR.6262Hayes et al 22 2012The United KingdomCross-sectional descriptive2620.0⩾50NR90.90Murray et al 16 2004AustraliaCross-sectional descriptive91418.3<2->40NR121121Fazel et al 23 2004The United KingdomRetrospective descriptive2030.066 ± 4.8NR.5656 Characteristics of Included Studies. Prevalence of Musculoskeletal Disorders Among Prisoners The pooled prevalence of MSDs among prisoners (both clinically diagnosed and self-reported) was 25% (95% Confidence Interval [95% CI] = 18%-33%) across all included studies. There was significant between-study heterogeneity, as shown by an I2 of 98.8% (P < .001) (Figure 2). Pooled prevalence of total (diagnosed and self-reported) MSDs. UK, the United Kingdom; USA, the United States of America; CI, confidence interval. Bias and Sensitivity Assessment A funnel plot of the standard errors vs effect sizes (prevalence of MSDs) of included studies is presented in Figure 3. The plot shows that there is no publication bias with a symmetrical distribution of the included studies around the pooled prevalence. The Egger test was not statistically significant (t = 1.66, P = .119), confirming the symmetry of the funnel plot. Furthermore, a leave-one-out sensitivity analysis reveals a range of pooled prevalence, 23.7% to 26.8% (Figure 4), which differs by less than 10% (<2.5 percentage points) from the pooled prevalence of 25%. Funnel plot of total (clinically diagnosed and self-reported) MSDs among prison inmates. Also shown (bottom right) is the result of the Egger test for asymmetry. Leave-one-out sensitivity analysis of the total (clinically diagnosed and self-reported) MSDs among prison inmates. Clinically Diagnosed Musculoskeletal Disorders Overall, 7/16 (44%) studies 11 -13,15,16,21,23 reported clinically diagnosed MSDs among prison inmates. The pooled prevalence of clinically diagnosed MSDs was 18% (95% CI = 13%-24%), with significantly high heterogeneity between studies (I2 = 87.6%, P < .001; Figure 5). The funnel plot and the Egger test show a symmetric distribution of studies (ie, no publication bias), and sensitivity analysis indicates that none of the included studies has a disproportionate influence (⩾10%) on the pooled prevalence (Supplemental Figures S2 and S3). Pooled prevalence of clinically diagnosed MSDs. UK, the United Kingdom; CI, confidence interval. Self-Reported Musculoskeletal Disorders Of the 16 studies, 11 (69%) included prison inmates with self-reported MSDs. 9 -11,14,15,17-20,22,24 The pooled prevalence of MSDs in the study population that self-reported was 30% (95% CI = 20%-39%), with between-study heterogeneity (I2 = 99.2%, P < .001) (Figure 6). The funnel plot shows a symmetrical distribution of studies, statistically supported by an Egger test, which was not significant (t = 1.66, P = .119). Leave-one-out sensitivity analysis yields pooled prevalences ranging from 27.9% to 32.6%, indicating no significant influence from any of the included studies (Supplemental Figures S4 and S5). Pooled prevalence of self-reported MSDs. UK, the United Kingdom; USA, the United States of America; CI, confidence interval. Discussion In this systematic review and meta-analysis, we present the prevalence of clinically diagnosed and self-reported MSDs among prison inmates. To the best of our knowledge, this review represents the first of its kind, dedicated to assessing MSDs among this unique population worldwide. The main findings of this review are as follows. First, our results show that overall, around 1 in 4 (25%) of prison inmates are suspected to suffer from either self-reported or clinically diagnosed MSDs. Furthermore, self-reported MSDs prevalence, based mostly on health status surveys of prison inmates, was found to be around 30% (~1 out of 3 inmates), with clinically diagnosed prevalence reported to be 18% (~ 1 in 5 inmates). Thus, clinically diagnosed MSDs are approximately twice as low as self-reported prevalence. The overall MSD prevalence reported here is lower compared with that reported in other populations. According to a study by Malik et al, 25 the prevalence of MSDs among the US general population may be around 54%, based on the 2012 National Health Interview Survey. The rate is similar to that reported in a national survey of Indian adults, with authors reporting a prevalence of approximately 54%, with an especially higher burden among older females. 26 The gender disparities in MSDs prevalence are also supported by analysis of the MSDs helpline calls data in Scotland performed by Walker-Bone et al, 27 where the authors reported a higher prevalence of women callers (60%) compared with men. Furthermore, occupational MSDs constitute a significant issue, especially among workers involved in manual handling or those with heavy mental workload, among others. For instance, in a cross-sectional survey of automotive assembly workers in Iran, Hosseini et al 28 reported a prevalence of over 44% of MSDs, especially in the neck and lower back, in this population. Similarly, in a systematic review by Jacquier-Bret and Gorce, including over 21 000 health care professionals, the prevalence of MSDs was found to be higher than reported in this study, with surgeons and dentists reporting over 66% prevalence of lower back pain. 29 Studies from other countries and regions have also corroborated the higher prevalence of MSDs among health care workers, with the prevalence of lower back pain ranging from 28% in Brazil up to 89% in Portugal among nursing workers.30,31 We hypothesize that the relatively lower MSD prevalence among prison inmates may be due to under-reporting, primarily due to lack of access to health care or health care professionals. This is potentially also influenced by other factors such as the sampling of the population in the included study and trust, as well as gender and age, factors that have been shown to influence the odds or MSDs32,33 significantly. To capture the actual burden of MSDs and other chronic diseases among prison inmates, the interplay of these complex issues may need to be addressed first in order to build trust and cater to the health needs of inmates. This study has several limitations that may affect the interpretation of the findings. First, the studies included do not cover all the regions of the world and thus may not represent the global picture of MSDs among prison inmates. Also, the difference between the self-reported and clinically diagnosed prevalence of MSDs reported in this study has been highlighted as a significant issue in health care research. Indeed, previous studies have shown similar discrepancies between self-reported and clinically diagnosed chronic diseases in various populations,34,35 which may compromise the validity of reported disease burden. Musculoskeletal disorders have been reported to be associated with multiple factors, including sex, history of smoking, occupation, mental health, and past health history, among others. We are unable to assess the relationship between these factors and the prevalence of MSDs among prisoners, as the included studies do not consistently report these factors. Finally, the significantly high between-studies heterogeneity indicates that the included studies differ in their design and execution, highlighting the need for unified guidelines for reporting on the health state of prison inmates. Irrespective of these limitations, quality assessment and statistical tests show that this study is robust with no significant evidence of a small-study effect. In sum, this study provides a comprehensive meta-analysis of MSDs prevalence among prison inmates across the world. We found the overall prevalence of both self-reported and clinically diagnosed MSDs to be lower than that of the general population. Yet, considering that prison inmates have significantly lower access to care, future studies should assess the influence of these and other peculiar factors on trust and the ability to capture the true health states of this population. Supplemental Material sj-docx-1-amd-10.1177_11795441261480697 – Supplemental material for Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis Supplemental material, sj-docx-1-amd-10.1177_11795441261480697 for Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis by Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, Fahad A. Salem and Jaber S. Alqahtani in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders sj-docx-2-amd-10.1177_11795441261480697 – Supplemental material for Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis Supplemental material, sj-docx-2-amd-10.1177_11795441261480697 for Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis by Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, Fahad A. Salem and Jaber S. Alqahtani in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders Footnotes ORCID iD: Jaber S. Alqahtani https://orcid.org/0000-0003-1795-5092 Author Contributions: Tope Oyelade, Arowosegbe Abayomi, and Jaber S. Alqahtani: Conceptualization, study design, and protocol registration. Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, Fahad A. Salem, and Jaber S. Alqahtani: Development of search strategies, systematic literature searches, and duplicate removal. Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, Fahad A. Salem, and Jaber S. Alqahtani: Title, abstract, and full-text screening against eligibility criteria. Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, Fahad A. Salem, and Jaber S. Alqahtani: Data extraction and risk of bias/quality assessment of included studies. Tope Oyelade and Jaber S. Alqahtani: Meta-analysis, and data synthesis. Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, FAS, and Jaber S. Alqahtani: Drafting of the original manuscript. Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, FAS, and Jaber S. Alqahtani: Critical revision of the manuscript for important intellectual content. Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, FAS, and Jaber S. Alqahtani: Final approval of the version to be published. Tope Oyelade: Guarantor, project supervision, and conflict resolution during the screening phase. All authors agree to be accountable for all aspects of the work to ensure its accuracy and integrity. Funding: The authors received no financial support for the research, authorship, and/or publication of this article. The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Data Availability Statement: All relevant data are within the article and its supporting information files. Supplemental Material: Supplemental material for this article is available online. References Associated Data Supplementary Materials sj-docx-1-amd-10.1177_11795441261480697 – Supplemental material for Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis Supplemental material, sj-docx-1-amd-10.1177_11795441261480697 for Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis by Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, Fahad A. Salem and Jaber S. Alqahtani in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders sj-docx-2-amd-10.1177_11795441261480697 – Supplemental material for Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis Supplemental material, sj-docx-2-amd-10.1177_11795441261480697 for Prevalence of Musculoskeletal Disorders Among Prison Inmates: A Systematic Review and Meta-Analysis by Tope Oyelade, Arowosegbe Abayomi, Sulaiman M. Almarkhan, Fahad A. Salem and Jaber S. Alqahtani in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders